Cynata Therapeutics Ltd is engaged in the development and commercialization of a proprietary mesenchymal stem cell (MSC) technology for potential human therapeutic use, which is branded as Cymerus... Show more
Industry Biotechnology
A.I.dvisor indicates that over the last year, CYYNF has been loosely correlated with HLOSF. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if CYYNF jumps, then HLOSF could also see price increases.
| Ticker / NAME | Correlation To CYYNF | 1D Price Change % | ||
|---|---|---|---|---|
| CYYNF | 100% | N/A | ||
| HLOSF - CYYNF | 39% Loosely correlated | N/A | ||
| DMAC - CYYNF | 30% Poorly correlated | +0.24% | ||
| PALI - CYYNF | 21% Poorly correlated | -5.47% | ||
| CVALF - CYYNF | 6% Poorly correlated | -4.41% | ||
| FAMDF - CYYNF | 2% Poorly correlated | N/A | ||
More | ||||